Literature DB >> 33596222

Impact of pre-analytic step duration on molecular diagnosis of toxoplasmosis for five types of biological samples.

Marie-Pierre Brenier-Pinchart1,2, Emmanuelle Varlet-Marie2,3, Florence Robert-Gangneux2,4, Denis Filisetti2,5, Juliette Guitard2,6, Yvon Sterkers2,7, Hélène Yera2,8, Hervé Pelloux1,2, Patrick Bastien2,7.   

Abstract

INTRODUCTION: Toxoplasma-PCR is essential to diagnose ocular, cerebral, disseminated and congenital toxoplasmosis. This multicenter study evaluated the impact of sample storage duration at +4°C on PCR assay performances in order to propose guidelines for the storage of samples during shipment or/and before PCR.
MATERIALS AND METHODS: Five matrices, amniotic (AF), cerebrospinal (CSF), and bronchoalveolar lavage fluids (BALF), whole blood (WB) and buffy coat (BC), were artificially spiked with different amounts of Toxoplasma gondii (20, 100, 500 tachyzoites per mL of sample) or with previously infected THP1 cells. DNA extractions were performed at day 0 and after 2, 4 and 7 days of storage at +4°C. Each extract was amplified at least twice by real-time PCR.
RESULTS: A total of 252 spiked samples was studied. No increase of crossing point was observed and all samples were positive for AF, BALF, BC and infected THP1-spiked WB after up to 7 days at 4°C. For CSF spiked with 20 parasites/mL, only 50% of PCR reactions were positive at D7 (p<0.05). For WB spiked with type II parasites, all reactions remained positive at D7 but amplifications were significantly delayed from D2; and for WB spiked with RH strain, the proportion of positive reactions decreased at D7.
CONCLUSION: The storage of clinical samples at +4°C is compatible with the molecular detection of T. gondii parasites. Provided that PCR assays are performed in duplicate, storage of samples is possible up to 7 days. However, from the fifth day onwards, and for samples susceptible to contain low parasitic loads, we recommend to perform the PCR in multiplicate.

Entities:  

Year:  2021        PMID: 33596222      PMCID: PMC7888589          DOI: 10.1371/journal.pone.0246802

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  32 in total

1.  Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii.

Authors:  Marie-Pierre Brenier-Pinchart; Elodie Capderou; Rose-Laurence Bertini; Sébastien Bailly; Hélène Fricker-Hidalgo; Emmanuelle Varlet-Marie; Jean-Benjamin Murat; Yvon Sterkers; Fériel Touafek; Patrick Bastien; Hervé Pelloux
Journal:  Diagn Microbiol Infect Dis       Date:  2015-04-24       Impact factor: 2.803

Review 2.  Management of toxoplasmosis in transplant recipients: an update.

Authors:  Céline Dard; Pierre Marty; Marie-Pierre Brenier-Pinchart; Cécile Garnaud; Hélène Fricker-Hidalgo; Hervé Pelloux; Christelle Pomares
Journal:  Expert Rev Anti Infect Ther       Date:  2018-07-02       Impact factor: 5.091

3.  The effect of sample storage on polymerase chain reaction-based detection of Toxoplasma gondii in amniotic fluids.

Authors:  A W Joss; D O Ho-Yen
Journal:  J Med Microbiol       Date:  1997-01       Impact factor: 2.472

4.  Freezing and storage at -20 °C provides adequate preservation of Toxoplasma gondii DNA for retrospective molecular analysis.

Authors:  Laurence Delhaes; Denis Filisetti; Marie-Pierre Brenier-Pinchart; Hervé Pelloux; Hélène Yéra; Frédéric Dalle; Yvon Sterkers; Emmanuelle Varlet-Marie; Feriel Touafek; Sophie Cassaing; Patrick Bastien
Journal:  Diagn Microbiol Infect Dis       Date:  2014-08-29       Impact factor: 2.803

5.  Long-term sera storage does not significantly modify the interpretation of toxoplasmosis serologies.

Authors:  C Dard; S Bailly; T Drouet; H Fricker-Hidalgo; M P Brenier-Pinchart; H Pelloux
Journal:  J Microbiol Methods       Date:  2017-01-16       Impact factor: 2.363

6.  Molecular diagnosis of toxoplasmosis: evaluation of automated DNA extraction using eMAG® (bioMérieux) on buffy coat, cerebrospinal and bronchoalveolar lavage fluids.

Authors:  Fanny Zhao; Lionnel Bulin; Hélène Fricker-Hidalgo; Quentin Renaut; Marie Gladys Robert; Cécile Garnaud; Hervé Pelloux; Marie-Pierre Brenier-Pinchart
Journal:  Clin Chem Lab Med       Date:  2020-02-25       Impact factor: 3.694

7.  Multicentric Evaluation of the Bio-Evolution Toxoplasma gondii Assay for the Detection of Toxoplasma DNA in Immunocompromised Patients.

Authors:  Nawel Ait Ammar; Hélène Yera; Jeanne Bigot; Françoise Botterel; Christophe Hennequin; Juliette Guitard
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

Review 8.  The global burden of congenital toxoplasmosis: a systematic review.

Authors:  Paul R Torgerson; Pierpaolo Mastroiacovo
Journal:  Bull World Health Organ       Date:  2013-05-03       Impact factor: 9.408

9.  Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes.

Authors:  Udo Reischl; Stéphane Bretagne; Dominique Krüger; Pauline Ernault; Jean-Marc Costa
Journal:  BMC Infect Dis       Date:  2003-05-02       Impact factor: 3.090

10.  Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.

Authors:  Florence Robert-Gangneux; Valeria Meroni; Damien Dupont; Françoise Botterel; José M Aguado Garcia; Marie-Pierre Brenier-Pinchart; Isabelle Accoceberry; Hamdi Akan; Isabella Abbate; Katia Boggian; Fabrizio Bruschi; Jordi Carratalà; Miruna David; Lubos Drgona; Olgica Djurković-Djaković; Maria Carmen Farinas; Francesca Genco; Effrossyni Gkrania-Klotsas; Andreas H Groll; Edward Guy; Cédric Hirzel; Nina Khanna; Özgür Kurt; Lia Monica Junie; Tiziana Lazzarotto; Oscar Len; Nicolas J Mueller; Patricia Munoz; Zoi Dorothea Pana; Emmanuel Roilides; Tijana Stajner; Christian van Delden; Isabelle Villena; Hervé Pelloux; Oriol Manuel
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.